MedTrace Logo

Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain

NCT03340818 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2024-08-07

No results posted yet for this study

Summary

A double-blind, placebo-controlled study to determine the efficacy of intradiscal injection of bone marrow concentrate on discogenic low back pain.

Conditions

  • Discogenic Pain

Interventions

OTHER

Bone Marrow Concentrate

Bone marrow concentrate is bone marrow harvested from the iliac crest and minimally processed in a centrifuge. It is then injected into the suspected painful disc (s) using fluoroscopic guidance

OTHER

Placebo

Injection of normal saline dorsal to the transverse process after sham bone marrow aspiration

Sponsors & Collaborators

  • APM Spine and Sports Physicians

    lead OTHER

Principal Investigators

  • David S Levi, MD · Jordan Young Institute

  • Scott I Horn, DO · Jordan Young Institute

  • Josh Levin, MD · Stanford University

  • Sara A Tyszko, PA-C · Jordan Young Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2024-08-07
Completion
2024-08-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03340818 on ClinicalTrials.gov